Clinical Trial Update: Phase II Study of Amithiozone (Thiacetazone) for Patients With Mycobacterium Avium Complex Pulmonary Disease [Phase 2]

View source ↗

Summary

Phase II study of Amithiozone (Thiacetazone) for Mycobacterium avium complex pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycobacterium Avium Complex Pulmonary Disease

Drugs mentioned

• Amithiozone (Thiacetazone)

Snippet

Sponsor: National Jewish Health | Conditions: Mycobacterium Avium-intracellulare Infection | Phase 2 | Status: COMPLETED